Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
FDA approved KOMBIGLYZE XR for type 2 diabetes mellitus now available in pharmacies

FDA approved KOMBIGLYZE XR for type 2 diabetes mellitus now available in pharmacies

BG Medicine enters agreement to develop galectin-3 test for Siemens' automated immunoassay platforms

BG Medicine enters agreement to develop galectin-3 test for Siemens' automated immunoassay platforms

22.5% implanted defibrillators are unnecessary: Study

22.5% implanted defibrillators are unnecessary: Study

Metabolon announces publication of 'Metabolomic Distinction and Insights into the Pathogenesis of Human Primary Dilated Cardiomyopathy'

Metabolon announces publication of 'Metabolomic Distinction and Insights into the Pathogenesis of Human Primary Dilated Cardiomyopathy'

Medical experts issue warning about common practice of tablet splitting

Medical experts issue warning about common practice of tablet splitting

FDA grants additional marketing exclusivity to INOMAX for pediatric BPD treatment

FDA grants additional marketing exclusivity to INOMAX for pediatric BPD treatment

Tablet splitting leads to inaccurate dosages

Tablet splitting leads to inaccurate dosages

Predictive value of plasma galectin-3 levels in heart failure patients: Study

Predictive value of plasma galectin-3 levels in heart failure patients: Study

20% of patients who received implantable cardioverter-defibrillators did not meet guidelines for receipt of ICD

20% of patients who received implantable cardioverter-defibrillators did not meet guidelines for receipt of ICD

GLUMETZA tablets are now available to wholesalers and physicians

GLUMETZA tablets are now available to wholesalers and physicians

New program may help reduce hospital readmission rates for high-risk seniors

New program may help reduce hospital readmission rates for high-risk seniors

Embryome Sciences announces $4M equity financing, changes name to ReCyte Therapeutics

Embryome Sciences announces $4M equity financing, changes name to ReCyte Therapeutics

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

Centocor Ortho Biotech files REMICADE sBLA for ulcerative colitis in pediatric patients

Centocor Ortho Biotech files REMICADE sBLA for ulcerative colitis in pediatric patients

FDA approves Endo's FORTESTA Gel for low testosterone

FDA approves Endo's FORTESTA Gel for low testosterone

Florida Hospital, Sanford-Burnham and Takeda enter obesity research collaboration

Florida Hospital, Sanford-Burnham and Takeda enter obesity research collaboration

Patients unresponsive to anti-anemia drug have higher risk of cardiovascular disease, death

Patients unresponsive to anti-anemia drug have higher risk of cardiovascular disease, death

HeartWare seeks FDA PMA approval for HeartWare Ventricular Assist System

HeartWare seeks FDA PMA approval for HeartWare Ventricular Assist System

Researchers receive $6.78 million NIH grant for community-based study on heart disease

Researchers receive $6.78 million NIH grant for community-based study on heart disease

22% of hospital admissions in 2008 were for patients over 75 years old: AHRQ

22% of hospital admissions in 2008 were for patients over 75 years old: AHRQ

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.